Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy

Cazeau, 2001, Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay, N Engl J Med, 344, 873, 10.1056/NEJM200103223441202 Abraham, 2002, Cardiac resynchronization in chronic heart failure, N Engl J Med, 346, 1845, 10.1056/NEJMoa013168 Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 Cleland, 2005, The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, 1539, 10.1056/NEJMoa050496 Dickstein, 2009, The European cardiac resynchronization therapy survey, Eur Heart J, 30, 2450, 10.1093/eurheartj/ehp359 Dickstein, 2018, CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11088 patients-who is doing what to whom and how?, Eur J Heart Fail, 20, 1039, 10.1002/ejhf.1142 Witte, 2006, Biventricular pacemaker upgrade in previously paced heart failure patients--improvements in ventricular dyssynchrony, J Card Fail, 12, 199, 10.1016/j.cardfail.2005.12.003 Fröhlich, 2010, Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling, Eur Heart J, 31, 1477, 10.1093/eurheartj/ehq065 Thijssen, 2011, Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders, J Am Coll Cardiol, 58, 2282, 10.1016/j.jacc.2011.08.038 Nägele, 2008, Hemodynamics and prognosis after primary cardiac resynchronization system implantation compared to “upgrade” procedures, Pacing Clin Electrophysiol, 31, 1265, 10.1111/j.1540-8159.2008.01176.x Kosztin, 2018, De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis, Heart Fail Rev, 23, 15, 10.1007/s10741-017-9652-1 Borleffs, 2010, Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications, Pacing Clin Electrophysiol, 33, 1013 Jones, 2008, Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications, Heart Rhythm, 5, 520, 10.1016/j.hrthm.2008.01.009 Barakat, 2017, Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: complexity, safety, and outcomes, Heart Rhythm, 14, 1807, 10.1016/j.hrthm.2017.08.019 Essebag, 2015, Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy, Circ Arrhythm Electrophysiol, 8, 152, 10.1161/CIRCEP.114.001997 Linde, 2018, Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II, Eur J Heart Fail, 20, 1457, 10.1002/ejhf.1235 Cheung, 2017, Trends and outcomes of cardiac resynchronization therapy upgrade procedures: a comparative analysis using a United States National Database 2003–2013, Heart Rhythm, 14, 1043, 10.1016/j.hrthm.2017.02.017 Bogale, 2011, The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades, Eur J Heart Fail, 13, 974, 10.1093/eurjhf/hfr085 Kusumoto, 2017, 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction, Heart Rhythm, 14, e503, 10.1016/j.hrthm.2017.09.001 Kearon, 2012, Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e419S, 10.1378/chest.11-2301 Poole, 2010, Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry, Circulation, 122, 1553, 10.1161/CIRCULATIONAHA.110.976076 Van Rees, 2011, Implantation-related complications of implantable cardioverter- defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials, J Am Coll Cardiol, 58, 995, 10.1016/j.jacc.2011.06.007 Yeo, 2017, Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003–2011, Heart Rhythm, 14, 1826, 10.1016/j.hrthm.2017.09.017 Lickfett, 2004, Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement, Europace, 6, 25, 10.1016/j.eupc.2003.09.001 Haghjoo, 2007, Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade, Europace, 9, 328, 10.1093/europace/eum019 Abu-El-Haija, 2015, Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients, J Am Heart Assoc, 4 Bernstein, 2014, Use of a lateral infraclavicular puncture to obtain proximal venous access with occluded subclavian/axillary venous systems for cardiac rhythm devices, Pacing Clin Electrophysiol, 37, 1017, 10.1111/pace.12375 Luthje, 2011, Acute and long-term feasibility of contralateral transvenous lead placement with subcutaneous, pre-sternal tunnelling in patients with chronically implanted rhythm devices, Europace, 13, 1004, 10.1093/europace/eur072 Worley, 2011, Subclavian venoplasty by the implanting physicians in 373 patients over 11 years, Heart Rhythm, 8, 526, 10.1016/j.hrthm.2010.12.014 Merkely, 2017, Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicenter clinical trial, Europace, 19, 1549